Kathleen Knights

2.8k citations
55 papers · 2.2k indexed · h-index 27
Topics
Pharmacogenetics and Drug Metabolism (32 papers)Drug Transport and Resistance Mechanisms (15 papers)Eicosanoids and Hypertension Pharmacology (15 papers)

In The Last Decade

Kathleen Knights

55 papers receiving 2.1k citations

Peers

Kathleen Knights
Comparison fields: 5 of 100
  • Pharmacology 1.3k
  • Molecular Biology 734
  • Oncology 727
  • Pharmacology 388
  • Pediatrics, Perinatology and Child Health 256
Replace Robin E. Pearce with:
Robin E. Pearce United States
P. Kremers Belgium
Ruth Hyland United Kingdom
G. M. Pacifici Italy
Miki Katoh Japan
Mikael Oscarson Sweden
A. David Rodrigues United States
A. David Rodrigues United States
S. Ball United States
Yukiharu Inui Japan
Kathleen Knights relative to Robin E. Pearce United States Robin E. Pearce's profile →
Citations per field
00.5×1.6×
Robin E. Pearce · 1×
Citations per year

Countries citing papers authored by Kathleen Knights

Since Specialization
Citations

This map shows the geographic impact of Kathleen Knights's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Knights with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Knights more than expected).

Fields of papers citing papers by Kathleen Knights

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Knights. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Knights. The network helps show where Kathleen Knights may publish in the future.

Co-authorship network of co-authors of Kathleen Knights

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Knights. A scholar is included among the top collaborators of Kathleen Knights based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Knights. Kathleen Knights is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 71
2 2
3 94
4 13
5 87
6 30
7 30
8 55
9 32
10 133
11 89
12 74
13 3
14 33
15 46
16 13
17 19
18 30
19 20
20 9

About Kathleen Knights

Kathleen Knights is a scholar working on Pharmacology, Biochemistry and Clinical Biochemistry, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (32 papers), Drug Transport and Resistance Mechanisms (15 papers) and Eicosanoids and Hypertension Pharmacology (15 papers). The work is most often cited by research in Pharmacology (1.3k citations), Clinical Biochemistry (204 citations) and Biochemistry (198 citations). Kathleen Knights has collaborated with scholars based in Australia, United Kingdom and Thailand. Frequent co-authors include John O. Miners, Peter I. Mackenzie, Andrew Rowland, David J. Elliot, Benedetta C. Sallustio, Kushari Bowalgaha, Arduino A. Mangoni, J. Brian Houston, Matthew J. Sykes and Peter J. Meffin. Their work appears in journals such as Analytical Biochemistry, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026